Free Trial

MNI POLITICAL RISK ANALYSIS – Global COVID-19 Tracker - Oct 23

COVID-19 Trends and Developments

  • The United States recorded its highest number of new cases since July 24 on October 22, with 71,671 cases added to the total. As the latest spike in cases continues to grow, the US Food and Drug Administration has given its approval to use the antiviral drug remdesivir (also known by its brand name Veklury) across the US to treat COVID-19 patients in hospital. This marks the FDA's first approval for a drug to treat the virus and comes days after the WHO said the drug had little-to-no impact on a patients' chances of survival. The FDA has said, though, that the drug can minimise the timeframe that individuals experience symptoms.
  • France registered 41,622 new cases on October 22, by some distance the country's largest 24 hour increase in infections. The previous one-day high (discounting the figures released on Mondays that cover the new weekend cases) was the 30,621 new cases recorded on October 15. Prime Minister Jean Castex announced the 2100-0600 curfew in place in Ile-de-France and eight cities would be extended to 38 more administrative depertements (covering 46mn people) and French Polynesia for a period of six weeks in an attempt to try to contain the virus.
  • The average number of new COVID-19 cases registerd per day across the past week in India has fallen to its lowest level since May 5. While the 55,835 new cases recorded on average per day over the last seven days still means India is recording the second-highest number of new cases behind the United States, it does show that the sustained increase in cases that formed a first wave in the country does appear to be slowing.

Chart 1. COVID-19 Cases and Fatalities, Nominal and % Chg Day-to-Day (5dma)

Source: JHU, MNI. As of 0700BST October 23. N.b. Each dot represents a single day's figures, data for past three months

Full article PDF attached below:

MNI POLITICAL RISK ANALYSIS – Global COVID-19 Tracker - Oct 23.pdf

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.